Derived the evidence for a potential role of G-CSF in the pathogenesis of AML / MDS, from only a few retrospective studies, thus hypothesis generation hypothesis generation be be conclusive. .. Check In an editorial, and Marijke Bontenbal, the Erasmus University Medical Center Rotterdam in the Netherlands, the possible biological mechanisms for the increased risk, and suggest that growth factor use has increased in recent years, remember. That the benefits that the benefits of adjuvant chemotherapy in breast cancer may far outweigh any risk of a second cancer. ? In clinical practice of adjuvant chemotherapy of adjuvant chemotherapy are of a different magnitude than the risk of secondary MDS or AML, they write.
Attribution to the Journal of the National Cancer Institute to offer in all coverage.. * Editorial: Touw IP, Bontenbal M. Granulocyte Colony – Stimulating Factor: Key actor or Innocent Bystander in the development of secondary myeloid malignancy? J Natl Cancer Inst 2007, 99: 183-186.NOTE: The Journal of the National Cancer Institute is published by Oxford University Press and with the with the National Cancer Institute.Continue Reading